Literature DB >> 21242658

Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection.

Jin-Wook Kim1, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee.   

Abstract

OBJECTIVES: The aim of this study was to examine the methylation status of intrahepatic hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and to elucidate the possible relationship between the cccDNA methylation and viral replicative activity in patients with HBV-related liver cirrhosis (HBV-LC).
METHODS: The methylation status of HBV cccDNA was investigated by bisulfite sequencing in nonneoplastic tissues from 12 patients with HBV-LC who underwent surgical resection for combined hepatocellular carcinoma. Clinical, biochemical and virologic factors were evaluated with respect to the degrees of cccDNA methylation. We also examined the effect of methylation of cccDNA on viral transcription by an in vitro transcription assay.
RESULTS: Variable degrees of CpG methylation were present in the HBV cccDNA from patients with HBV-LC. Old age, low serum HBV DNA levels and low virion productivity were significantly associated with elevated cccDNA methylation. Virion productivity of cccDNA was also lower in HepAD38 cells with a higher degree of cccDNA methylation. In vitro transcription assays showed that the transcriptional activity of HBV cccDNA was suppressed by increased methylation of cccDNA.
CONCLUSIONS: Increased CpG methylation of cccDNA is associated with old age, low serum HBV DNA levels and suppressed replicative activity in HBV-LC.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242658     DOI: 10.1159/000321450

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  26 in total

Review 1.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

2.  Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis.

Authors:  Xue-Li Jin; Suk Kyun Hong; Hwajung Kim; Sun-Kyung Lee; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

3.  Detection of HBV cccDNA Methylation from Clinical Samples by Bisulfite Sequencing and Methylation-Specific PCR.

Authors:  Yongmei Zhang; Richeng Mao; Haitao Guo; Jiming Zhang
Journal:  Methods Mol Biol       Date:  2017

Review 4.  Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.

Authors:  Jennifer J Chang; Neaka Mohtashemi; Debika Bhattacharya
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

Review 5.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

Review 6.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

7.  Two Populations of Viral Minichromosomes Are Present in a Geminivirus-Infected Plant Showing Symptom Remission (Recovery).

Authors:  Esther Adriana Ceniceros-Ojeda; Edgar Antonio Rodríguez-Negrete; Rafael Francisco Rivera-Bustamante
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 8.  Advanced Strategies for Eliminating the cccDNA of HBV.

Authors:  Jingwu Dong; Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Dig Dis Sci       Date:  2017-11-20       Impact factor: 3.199

9.  Comparative analysis of CpG islands among HBV genotypes.

Authors:  Yongmei Zhang; Chenxiao Li; Yijun Zhang; Haoxiang Zhu; Yaoyue Kang; Hongyan Liu; Jinyu Wang; Yanli Qin; Richeng Mao; Yi Xie; Yuxian Huang; Jiming Zhang
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

10.  Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes.

Authors:  Fei Liu; Matthew Campagna; Yonghe Qi; Xuesen Zhao; Fang Guo; Chunxiao Xu; Sichen Li; Wenhui Li; Timothy M Block; Jinhong Chang; Ju-Tao Guo
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.